Key Takeaways Zimmer Biomet's growth is driven by knee segment strength and expanding cementless implant adoption.ZBH boosted innovation via Monogram acquisition and robotics, with commercialization eyed for 2027.High debt levels and intense competition remain ZBH's key challenges despite stable market conditions.Zimmer Biomet (ZBH) appears well-positioned for growth in the coming quarters, supported by the continued execution of its market strategies centered on People and Culture, Operational Excellence, ...